• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要碳源对微生物组形成及药物和个人护理品生物转化的影响。

Impact of primary carbon sources on microbiome shaping and biotransformation of pharmaceuticals and personal care products.

机构信息

Department of Civil and Environmental Engineering, Colorado State University, 1301 Campus Delivery, Fort Collins, CO, 80523, USA.

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, 80045, USA.

出版信息

Biodegradation. 2019 Jun;30(2-3):127-145. doi: 10.1007/s10532-019-09871-0. Epub 2019 Feb 28.

DOI:10.1007/s10532-019-09871-0
PMID:30820709
Abstract

Knowledge of the conditions that promote the growth and activity of pharmaceutical and personal care product (PPCP)-degrading microorganisms within mixed microbial systems are needed to shape microbiomes in biotreatment reactors and manage process performance. Available carbon sources influence microbial community structure, and specific carbon sources could potentially be added to end-of-treatment train biotreatment systems (e.g., soil aquifer treatment [SAT]) to select for the growth and activity of a range of microbial phylotypes that collectively degrade target PPCPs. Herein, the impacts of primary carbon sources on PPCP biodegradation and microbial community structure were explored to identify promising carbon sources for PPCP biotreatment application. Six types of primary carbon sources were investigated: casamino acids, two humic acid and peptone mixtures (high and low amounts of humic acid), molasses, an organic acids mixture, and phenol. Biodegradation was tracked for five PPCPs (diclofenac, 5-fluorouracil, gemfibrozil, ibuprofen, and triclosan). Primary carbon sources were found to differentially impact microbial community structures and rates and efficiencies of PPCP biotransformation. Of the primary carbon sources tested, casamino acids, organic acids, and phenol showed the fastest biotransformation; however, on a biomass-normalized basis, both humic acid-peptone mixtures showed comparable or superior biotransformation. By comparing microbial communities for the different primary carbon sources, abundances of unclassified Beijerinckiaceae, Beijerinckia, Sphingomonas, unclassified Sphingomonadaceae, Flavobacterium, unclassified Rhizobiales, and Nevskia were statistically linked with biotransformation of specific PPCPs.

摘要

了解促进混合微生物系统中药物和个人护理产品 (PPCP) 降解微生物生长和活性的条件对于塑造生物处理反应器中的微生物组和管理工艺性能是必要的。可用的碳源会影响微生物群落结构,并且特定的碳源可能会被添加到处理后生物处理系统(例如土壤-含水层处理 [SAT])中,以选择一系列能够降解目标 PPCP 的微生物类群的生长和活性。在此,研究了主要碳源对 PPCP 生物降解和微生物群落结构的影响,以确定 PPCP 生物处理应用的有前途的碳源。研究了六种主要碳源:水解酪蛋白、两种腐殖酸和蛋白胨混合物(高和低含量的腐殖酸)、糖蜜、有机酸混合物和苯酚。跟踪了五种 PPCP(双氯芬酸、5-氟尿嘧啶、吉非罗齐、布洛芬和三氯生)的生物降解情况。发现主要碳源会对微生物群落结构以及 PPCP 生物转化的速率和效率产生不同的影响。在所测试的主要碳源中,水解酪蛋白、有机酸和苯酚表现出最快的生物转化;然而,基于生物量归一化,两种腐殖酸-蛋白胨混合物显示出可比或更高的生物转化。通过比较不同主要碳源的微生物群落,可以发现未分类的 Beijerinckiaceae、Beijerinckia、Sphingomonas、未分类的 Sphingomonadaceae、Flavobacterium、未分类的 Rhizobiales 和 Nevskia 的丰度与特定 PPCP 的生物转化统计学上相关。

相似文献

1
Impact of primary carbon sources on microbiome shaping and biotransformation of pharmaceuticals and personal care products.主要碳源对微生物组形成及药物和个人护理品生物转化的影响。
Biodegradation. 2019 Jun;30(2-3):127-145. doi: 10.1007/s10532-019-09871-0. Epub 2019 Feb 28.
2
Impact of inoculum sources on biotransformation of pharmaceuticals and personal care products.接种源对药品和个人护理用品生物转化的影响。
Water Res. 2017 Nov 15;125:227-236. doi: 10.1016/j.watres.2017.08.041. Epub 2017 Aug 21.
3
Removal of pharmaceuticals and personal care products during water recycling: microbial community structure and effects of substrate concentration.水回收过程中药物和个人护理产品的去除:微生物群落结构及底物浓度的影响
Appl Environ Microbiol. 2014 Apr;80(8):2440-50. doi: 10.1128/AEM.03693-13. Epub 2014 Feb 7.
4
Biodegradation of pharmaceuticals and personal care products in the sequential combination of activated sludge treatment and soil aquifer treatment.在活性污泥处理和土壤-含水层处理的连续组合中,药物和个人护理产品的生物降解。
Environ Technol. 2020 Jan;41(3):378-388. doi: 10.1080/09593330.2018.1499810. Epub 2018 Jul 30.
5
Biological removal of pharmaceuticals and personal care products during laboratory soil aquifer treatment simulation with different primary substrate concentrations.不同初始基质浓度条件下实验室土壤含水层处理模拟中药物和个人护理产品的生物去除。
Water Res. 2012 May 1;46(7):2365-75. doi: 10.1016/j.watres.2012.02.001. Epub 2012 Feb 11.
6
Biotransformation of trace organic chemicals in the presence of highly refractory dissolved organic carbon.痕量有机化学品在高难降解溶解有机碳存在下的生物转化。
Chemosphere. 2019 Jan;215:33-39. doi: 10.1016/j.chemosphere.2018.09.166. Epub 2018 Sep 29.
7
Degradation and adsorption of selected pharmaceuticals and personal care products (PPCPs) in agricultural soils.农业土壤中选定的药品和个人护理产品(PPCPs)的降解和吸附。
Chemosphere. 2009 Nov;77(10):1299-305. doi: 10.1016/j.chemosphere.2009.09.063. Epub 2009 Oct 22.
8
Microbial community structure and pharmaceuticals and personal care products removal in a membrane bioreactor seeded with aerobic granular sludge.好的,我已经了解任务,请提供需要翻译的文本。
Appl Microbiol Biotechnol. 2015 Jan;99(1):425-33. doi: 10.1007/s00253-014-5984-0. Epub 2014 Aug 7.
9
Role of primary substrate composition on microbial community structure and function and trace organic chemical attenuation in managed aquifer recharge systems.主要基质组成对管理含水层补给系统中微生物群落结构与功能及微量有机化学物质衰减的作用
Appl Microbiol Biotechnol. 2014 Jun;98(12):5747-56. doi: 10.1007/s00253-014-5677-8. Epub 2014 Mar 26.
10
Quantifying PPCP interaction with dissolved organic matter in aqueous solution: combined use of fluorescence quenching and tandem mass spectrometry.定量研究水溶液中 PPCP 与溶解有机质的相互作用:荧光猝灭法与串联质谱联用。
Water Res. 2012 Mar 15;46(4):943-54. doi: 10.1016/j.watres.2011.11.061. Epub 2011 Nov 26.

引用本文的文献

1
Fibrate pharmacogenomics: expanding past the genome.纤维酸类药物遗传学:超越基因组。
Pharmacogenomics. 2020 Mar;21(4):293-306. doi: 10.2217/pgs-2019-0140. Epub 2020 Mar 17.